{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:55:10Z","timestamp":1772726110397,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ygyno.2017.09.001","type":"journal-article","created":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T01:05:27Z","timestamp":1504746327000},"page":"262-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer"],"prefix":"10.1016","volume":"147","author":[{"given":"Renee A.","family":"Cowan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayashree","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radhika","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara C.","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2017.09.001_bb0005","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1200\/JCO.2016.68.6907","article-title":"Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of clinical oncology clinical practice guideline","volume":"34","author":"Wright","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2014.07.002","article-title":"A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer","volume":"134","author":"Suidan","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1006\/gyno.2001.6312","article-title":"What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer?","volume":"82","author":"Eisenkop","year":"2001","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0020","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2007.04.049","article-title":"Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection","volume":"197","author":"Hoffman","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2 Suppl","key":"10.1016\/j.ygyno.2017.09.001_bb0030","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ygyno.2008.07.053","article-title":"Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy\/resection, splenectomy, and distal pancreatectomy","volume":"111","author":"Kehoe","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0035","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/IGC.0000000000000597","article-title":"Surgical techniques for diaphragmatic resection during Cytoreduction in advanced or recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"26","author":"Bogani","year":"2016","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.09.001_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2010.05.031","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas","volume":"119","author":"Chi","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0050","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-014-3446-7","article-title":"Success rate and safety of tumor debulking with diaphragmatic surgery for advanced epithelial ovarian cancer and peritoneal cancer","volume":"291","author":"Saitou","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0055","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00004728-198611000-00007","article-title":"Superior diaphragmatic lymph nodes: CT assessment","volume":"10","author":"Aronberg","year":"1986","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"Pt 3","key":"10.1016\/j.ygyno.2017.09.001_bb0060","first-page":"453","article-title":"The role of the diaphragm in lymphatic absorption from the peritoneal cavity","volume":"186","author":"Abu-Hijleh","year":"1995","journal-title":"J. Anat."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0009-9260(97)80034-7","article-title":"The significance of paracardiac lymph node enlargement in ovarian cancer","volume":"52","author":"Holloway","year":"1997","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0070","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","article-title":"Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0075","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ygyno.2013.05.040","article-title":"Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis","volume":"130","author":"Chang","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0080","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1245\/s10434-010-0964-9","article-title":"Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)","volume":"17","author":"Wimberger","year":"2010","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0085","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2017.02.023","article-title":"Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?","volume":"145","author":"Sioulas","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/01.AOG.0000192407.04428.bb","article-title":"Aggressive surgical effort and improved survival in advanced-stage ovarian cancer","volume":"107","author":"Aletti","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0105","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2017.09.001_bb0110","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1016\/j.ygyno.2010.12.190","article-title":"The feasibility of mediastinal lymphadenectomy in the management of advanced and recurrent ovarian carcinoma","volume":"120","author":"Diaz","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0115","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1245\/s10434-009-0486-5","article-title":"Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery","volume":"16","author":"Lim","year":"2009","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ygyno.2015.06.002","article-title":"Transdiaphragmatic cardiophrenic lymph node resection for stage IV ovarian cancer","volume":"138","author":"LaFargue","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gore.2016.05.006","article-title":"Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer","volume":"17","author":"LaFargue","year":"2016","journal-title":"Gynecol. Oncol. Rep."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2016.03.012","article-title":"Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer","volume":"141","author":"Prader","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0135","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ygyno.2012.12.023","article-title":"Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer","volume":"129","author":"Yoo","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2010.07.017","article-title":"Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer","volume":"119","author":"Bashir","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0145","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/IGC.0000000000000983","article-title":"Feasibility of transabdominal Cardiophrenic lymphnode dissection in advanced ovarian cancer: initial experience at a tertiary center","volume":"27","author":"Garbi","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.09.001_bb0150","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1245\/s10434-015-5015-0","article-title":"Preoperative prediction of Cardiophrenic lymph node metastasis in advanced ovarian cancer using computed tomography","volume":"23","author":"Kim","year":"2016","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0155","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/IGC.0b013e3181e833f5","article-title":"Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer","volume":"20","author":"Kolev","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2017.09.001_bb0160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/annonc\/mdv500","article-title":"Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG oncology\/gynecologic oncology group study","volume":"27","author":"Tewari","year":"2016","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2017.09.001_bb0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/AOG.0b013e31826981de","article-title":"Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer","volume":"120","author":"Wright","year":"2012","journal-title":"Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825817312702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T22:52:01Z","timestamp":1535410321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825817312702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0090825817312702"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.09.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2017.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}